Appendix B: Panel Roster and Financial Disclosures
Hepatitis B Virus
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Debika Bhattacharya | University of California, Los Angeles, David Geffen School of Medicine | Gilead Sciences | Research Support (paid to institution) |
| Laura Cooley | Centers for Disease Control and Prevention | None | N/A |
| Claudia Hawkins | Northwestern University, Feinberg School of Medicine | None | N/A |
| Marion Peters | Northwestern University, Feinberg School of Medicine | Aligos Therapeutics Antios Therapeutics |
Scientific Advisory Board |
| Chloe Thio* | Johns Hopkins University, School of Medicine | Allovir | Scientific Advisory Board |
| Key: * = Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
|||
Download Guidelines
- Section OnlyPDF (276.93 KB)
- Full GuidelinePDF (5.45 MB)
- Tables OnlyPDF (886.23 KB)